Theragen Overview
- Year Founded
-
2014
- Status
-
Private
- Employees
-
106
- Latest Deal Type
-
Debt - PPP
- Investors
-
1
Theragen General Information
Description
Developer of a therapeutic technology intended for body healing and pain relief. The company's technology delivers effective and safe therapeutic energy to the body to treat pain and disease and heal tissue, enabling patients to get relief from various kinds of pain and live a healthy life.
Contact Information
Website
www.theragen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Other Healthcare Technology Systems
Primary Office
- 10407 Centurion Parkway North
- Building 400, Suite 100
- Jacksonville, FL 32256
- United States
+1 (888) 000-0000
Theragen Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Debt - PPP | 15-Apr-2020 | 000.00 | Completed | Generating Revenue | ||
| 1. Early Stage VC (Series A1) | 21-Jun-2017 | 000.00 | 000.00 | 000.00 | Completed | Generating Revenue |
Theragen Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Theragen Patents
Theragen Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-11759637-B2 | Systems, methods and devices for electrical stimulation therapy | Active | 05-Feb-2021 | 00000000000 | 00 |
| US-11717685-B2 | Therapeutic stimulator system | Active | 05-Feb-2021 | 00000000000 | 00 |
| US-20220323754-A1 | Therapeutic stimulator system | Active | 05-Feb-2021 | 00000000000 | |
| US-11426574-B1 | Systems, methods and devices for electrical stimulation therapy | Active | 05-Feb-2021 | 00000000000 | 00 |
| US-20220249843-A1 | Therapeutic stimulator system | Active | 05-Feb-2021 | A61N1/0464 |
Theragen Executive Team (8)
Theragen Board Members (5)
| Name | Representing | Role | Since |
|---|---|---|---|
| Alex Evans | Theragen | Co-Founder & Board Member | 000 0000 |
| Jan Buck | Theragen | Co-Founder & Board Member | 000 0000 |
| Kimball Chen | Theragen | Co-Founder & Chairman | 000 0000 |
| Matthew Rice | Ballast Point Ventures | Board Member | 000 0000 |
Theragen Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Theragen Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Ballast Point Ventures | Venture Capital | Minority | 000 0000 | 000000 0 |
Theragen Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000000 000 | 18-Aug-2015 | 0000000000 | Therapeutic Devices | 0000 0000 |